Division of Metabolism(Biochemical Genetics) The Children's Hospital of Philadelphia 3501 Civic center blvd #9054.
215 590 3376

Dr. Ficicioglu is developing algorithms for the effective short and long-term care of patients detected by newborn screening, and new drugs to treat lysosomal storage disorders.

Associate Professor of Pediatrics at the Children's Hospital of Philadelphia (2011– present)
Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia (2002 – 2011)
PhD, Histology & Embryology, University of Marmara (1996)
MD, University of Istanbul, Cerrahpasa Medical School ( with High Honors) (1985)
Selected Publications
Chadwick S, Fitzgerald K, Weiss B, Ficicioglu C. Thirteen patients with MAT1A mutations detected through newborn screening: 13 years experience. JIMD report. 2014.
Coughlin CR, Hyland K,Randall R,Ficicioglu C. Dihydropteridine reductase deficiency and treatment with tetrahydrobiopterin: A case report.. JIMD reports. 2013.
Ficicioglu C, Dubroff JG, Thomas N , Gallagher PR, Burfield J, Hussa C. Randall R. Zhuang H. A pilot study of fluorodeoxyglucose positron emission tomography findings in patients with phenylketonuria before and during sapropterin supplementation. Journal of Clinical Neurology. 2013.
Hazard FK, Ficicioglu CH, Ganesh J, Ruchelli ED.. Liver pathology in infantile mitochondrial DNA depletion syndrome. Pediatr Dev Pathol. 2013.